Hologic Posts Upbeat Q1 Results, Lifts Full-Year Forecast

Hologic, Inc. (NASDAQ: HOLX) reported better-than-expected results for the fiscal second quarter and raised its full-year forecast.The Bedford, Massachusetts-based company posted quarterly net income of $47.8 million, or $0.17 per share, versus a year-ago loss of $16.8 million, or $0.06 per share. Excluding one-time items, the company's earnings rose 10.8 percent to $0.41 per share.Its revenue rose 4.9 percent year-over-year to $655.5 million. However, analysts were expecting earnings of $0.39 per share on revenue of $645.5 million.The average estimate among 14 Estimize users was for earnings of $0.40 per share and revenue of $647.37 million.U.S. revenues gained 6.8 percent to $495.2 million, while international revenue slipped 0.7 percent to $160.3 million in the quarter.Adjusted non-GAAP EBITDA rose 7.3 percent ti $238.6 million in the second quarter.Hologic ended the quarter with cash and equivalents of $675.1 million."We posted strong organic revenue growth across the board for a second straight quarter, while profitability increased at an even faster rate," said Steve MacMillan, Hologic's President and Chief Executive Officer. "As a Company, we have come a long way in a short period of time. While we focus on continuing to improve our performance, we are increasingly confident in our people and products, and are therefore further raising our financial outlook for the year."For the current quarter, Hologic projects earnings of $0.38 to $0.39 per share, on revenue of $645 million to $655 million. Analysts had expected earnings of $0.39 per share on revenue of $648.77 million.For the full year, Hologic now projects earnings of $1.57 to $1.59 per share, on revenue of 2.6 billion to $2.62 billion.Hologic shares finished down 1.15 percent at $32.66 during regular trading hours.